Alice et al.’s study33 found that peripheral PD-1+CD8+ T cells indicate tumour-specific CD8+ T cells and are associated with immune responses induced by therapies blocking the PD-1 pathway in lung cancer patients. Here, CD8A is linked to lung cancer.